Submission date
23/08/2006
Registration date
30/10/2006
Last edited
19/09/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Retrospectively registered
? Protocol not yet added
? SAP not yet added
? Results not yet added and study completed for more than 1 year
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Robert Milongo

ORCID ID

Contact details

AGDUC
Hôpital La Tronche
Grenoble
38 700
France

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

1445

Study information

Scientific title

Acronym

Study hypothesis

Evaluation of a new Peritoneal Dialysis (PD) dressing.

Ethics approval(s)

Submitted to CPP Grenoble (reference number: 06-GAMB-1), will receive verdict on 20th September 2006.

Study design

Monocentric, open, comparative study

Primary study design

Observational

Secondary study design

Single-centre

Study setting(s)

Not specified

Study type

Treatment

Patient information sheet

Condition

Chronic renal failure

Intervention

Evaluation of dressing advantages via questionnaires

Intervention type

Other

Primary outcome measure

Dressing advantages are evaluated via questionnaires, which have to be filled in at specific time schedule. Comfort and safety evaluation will be performed by the patient at the end of each period of product use (end of PD Immo use and end of usual dressing use).

Secondary outcome measures

Handling is also evaluated via the patient questionnaire.
The incidence of Adverse Events (AE) will be followed during the study period.

Overall study start date

25/09/2006

Overall study end date

25/11/2006

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Patients with well healed exit site
2. Patients treated for at least three months in peritoneal dialysis irrespective of the treatment mode
3. Patients with healthy skin judged by investigator
4. Patients aged 18 years and older
5. Patients having signed a written consent (informed consent) to participate in the study

Participant type(s)

Patient

Age group

Adult

Lower age limit

18 Years

Sex

Both

Target number of participants

20

Participant exclusion criteria

1. Patients treated in hemodialysis
2. Patients with diagnosed abdominal pain not related with PD-solution
3. Peritonitis within one month prior to the study
4. Presence of exit-site, tunnel infection
5. Patients with ongoing peritonitis
6. Patients participating in other studies during the period of this study
7. Patients practising swimming
8. Patients under guardianship
9. Pregnancy, lactation

Recruitment start date

25/09/2006

Recruitment end date

25/11/2006

Locations

Countries of recruitment

France

Study participating centre

AGDUC
Grenoble
38 700
France

Sponsor information

Organisation

Gambro Industries (France)

Sponsor details

Clinical Affairs Department
61 Avenue Tony Garnier
Lyon
69 007
France

Sponsor type

Industry

Website

http://www.gambro.com/start.aspx?id=752

ROR

https://ror.org/01mgtdr23

Funders

Funder type

Industry

Funder name

Gambro Industries (France)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?

Additional files

Editorial Notes